In the basic research area, we recently reported that incretin expression was down-regulated under diabetic conditions [39] and that incretin-related drugs exerted more beneficial anti-arteriosclerosis at an early stage of diabetes [41]. The gene discussed is GCG; the disease is arteriosclerosis.